Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hyundai Bioscience Co., Ltd.

Clinical trials sponsored by Hyundai Bioscience Co., Ltd., explained in plain language.

Hyundai Bioscience 048410 KOSDAQ

Hyundai Bioscience is a South Korean biotech company developing pharmaceuticals and health products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

Old drug, new hope: niclosamide combo targets resistant prostate cancer

Disease control Not yet recruiting

This early-stage trial tests whether adding CP-PCA07 (a form of niclosamide, a drug used for tapeworm infections) to the standard drug enzalutamide can safely help men with castration-resistant prostate cancer that has stopped responding to treatment. The study involves 18 men an…

Phase: PHASE1 • Sponsor: Hyundai Bioscience Co., Ltd. • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC